Back to Screener

RxSight, Inc. Common Stock (RXST)

Price$7.44

Favorite Metrics

Price vs S&P 500 (26W)-7.42%
Price vs S&P 500 (4W)8.67%
Market Capitalization$314.04M

All Metrics

Book Value / Share (Quarterly)$6.68
P/TBV (Annual)11.72x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)40.00%
Cash Flow / Share (Quarterly)$-0.47
Price vs S&P 500 (YTD)-31.11%
Gross Margin (TTM)76.60%
Net Profit Margin (TTM)-28.96%
EPS (TTM)$-0.95
10-Day Avg Trading Volume0.75M
EPS Excl Extra (TTM)$-0.95
Revenue Growth (5Y)55.73%
EPS (Annual)$-0.95
ROI (Annual)-14.12%
Gross Margin (Annual)76.60%
Net Profit Margin (5Y Avg)-90.98%
Cash / Share (Quarterly)$5.53
Revenue Growth QoQ (YoY)-18.91%
ROA (Last FY)-12.49%
Revenue Growth TTM (YoY)-3.89%
EBITD / Share (TTM)$-1.10
ROE (5Y Avg)-32.74%
Operating Margin (TTM)-35.84%
Cash Flow / Share (Annual)$-0.47
P/B Ratio1.14x
P/B Ratio (Quarterly)1.55x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.19x
Net Interest Coverage (TTM)-18.46x
ROA (TTM)-12.54%
EPS Incl Extra (Annual)$-0.95
Current Ratio (Annual)10.95x
Quick Ratio (Quarterly)9.58x
3-Month Avg Trading Volume0.89M
52-Week Price Return-47.61%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.50
P/S Ratio (Annual)2.34x
Asset Turnover (Annual)0.43x
52-Week High$16.74
Operating Margin (5Y Avg)-96.66%
EPS Excl Extra (Annual)$-0.95
CapEx CAGR (5Y)8.56%
26-Week Price Return1.33%
Quick Ratio (Annual)9.58x
13-Week Price Return-21.30%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)10.95x
Enterprise Value$294.181
Revenue / Share Growth (5Y)42.59%
Asset Turnover (TTM)0.43x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.18x
Pretax Margin (Annual)-28.91%
Cash / Share (Annual)$5.53
3-Month Return Std Dev57.46%
Gross Margin (5Y Avg)54.24%
Net Income / Employee (TTM)$-0
ROE (Last FY)-14.13%
Net Interest Coverage (Annual)-23.56x
EPS Basic Excl Extra (Annual)$-0.95
Receivables Turnover (TTM)5.03x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.95
Receivables Turnover (Annual)5.03x
ROI (TTM)-14.04%
P/S Ratio (TTM)2.34x
Pretax Margin (5Y Avg)-90.95%
Revenue / Share (Annual)$3.29
Tangible BV / Share (Annual)$3.18
Price vs S&P 500 (52W)-82.70%
Year-to-Date Return-26.97%
5-Day Price Return7.94%
EPS Normalized (Annual)$-0.95
ROA (5Y Avg)-23.49%
Net Profit Margin (Annual)-28.96%
Month-to-Date Return23.54%
Cash Flow / Share (TTM)$-1.54
EBITD / Share (Annual)$-1.18
Operating Margin (Annual)-35.84%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-26.55%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.95
P/TBV (Quarterly)6.52x
P/B Ratio (Annual)1.55x
Inventory Turnover (TTM)1.18x
Pretax Margin (TTM)-28.91%
Book Value / Share (Annual)$6.68
Price vs S&P 500 (13W)-24.17%
Beta1.32x
Revenue / Share (TTM)$3.27
ROE (TTM)-14.05%
52-Week Low$5.90

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.63
2.63
2.63
2.63

Industry Peers — Ophthalmic Goods(5)

SymbolP/E Ratio (Annual)ROE (TTM)Revenue Growth (5Y)Indicated Dividend Yield (Annual)Price
RXSTRxSight, Inc. Common Stock
-14.05%55.73%$7.44
COOThe Cooper Companies, Inc. Common Stock
36.47x4.83%10.98%0.02%$69.46
BLCOBausch + Lomb Corporation
-5.61%8.38%$16.76
WRBYWarby Parker Inc.
1889.51x0.45%17.24%$25.89
EYENational Vision Holdings, Inc. Common Stock
68.41x3.47%3.03%$25.49
STAAStaar Surgical Co
-23.24%7.93%$25.53

About

RxSight Inc is a medical technology company specializing in light adjustable intraocular lenses for cataract surgery. Its proprietary technology allows surgeons to customize and optimize patient vision outcomes post-surgery, reducing the need for corrective eyewear and improving patient satisfaction. The company manufactures light adjustable lenses and related capital equipment for the ophthalmology market.